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CT Findings of Atypical Adenomatous
Hyperplasia in the Lung
Objective: The aim of this study was to analyze the computed tomographic
(CT) findings of atypical adenomatous hyperplasia (AAH) in the lung.
Materials and Methods: The CT findings of AAHs in eight patients were retro-
spectively reviewed. The CT findings of each AAH lesion were evaluated for mul-
tiplicity, location, shape, size and internal density of the lesion, the interface
between the normal lung and the lesion, the internal features within the lesion
and any change of the lesion on the follow-up CT scans (range: 33 to 540 days;
average: 145.3 days).
Results: The eight patients consisted of three men and five women (age range:
43 71 years). Six of eight patients were asymptomatic. Four of them (50%) had
synchronous malignancies in the lung: adenocarcinoma of the lung (n = 3), and
metastatic squamous cell carcinoma from the uterus (n = 1). We could identify
and evaluate eleven AAH nodules in seven patients on the CT scans. Three
patients had multiple AAHs. Seven of the 11 lesions (64%) were located in the
upper lobe. All the AAHs showed a well-defined oval or round shape and pure
ground-glass opacity (GGO) without any solid component (size: 3.9 3 mm to 19
17 mm; internal attenuation:  467 to  785 HU). All the AAHs showed no
change of their size and internal density on the follow-up CT scans.
Conclusion: Atypical adenomatous hyperplasia is often associated with malig-
nancy. This tumor is shown on CT as persistent well-defined oval or round nodu-
lar GGOs without solid components, and it does not change on the follow-up CT.
typical adenomatous hyperplasia of the lung (AAH) is defined as a
peripheral focal proliferation of atypical cuboidal or columnar epitheial
cells along the alveoli and respiratory bronchioles (1). Its morphological
similarity and recent molecular biological analysis have suggested that AAH could be
a precursor lesion or even an early lesion of well-differentiated adenocarcinoma of the
peripheral lung (2 6). In past, the AAH that could not be detected on the radiologic
examinations before surgery was discovered incidentally in the surgically resected
specimens from lung cancer patients, and this lesion was predominantly seen in
adenocarcinoma patients (7). However, the number of radiologically detected AAH
lesions has been increasing in Japan due to the wide-spread use of CT in clinical
practice and also because of the mass screening for early lung cancer (8). Since mass
screening for early lung cancer using CT is prevalent in other countries, including
Korea, the radiologically detected AAH will increase dramatically as it did in Japan.
To the best of our knowledge, some investigators have reported the radiologic and
clinical features or the pathologic characteristics of AAH, but there are few reports in
the radiologic literature that give a comprehensive assessment about AAH in the
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Aradiologic literature. Moreover, there is no report about
AAH occurring in the Korean population. Thus, the aim of
this study was to analyze the CT findings of AAH.
MATERIALS AND METHODS
Between May 2004 and July 2005, AAHs were
pathologically confirmed in eight patients at our institution.
Five patients had undergone standard thoracotomy either
by lobectomy (n = 2), segmentectomy (n = 1), or wedge
resection (n = 2), and three patients had video-assisted
thoracic surgery (VATS) performed on them. This study
was conducted retrospectively with these eight patients. 
Clinical Features of the AAH Patients
We reviewed the medical records using the electronic
medical records system of our hospital. The following
clinical features of AAH patients were recorded: gender,
age, smoking history, the presence of symptom, a past
history of diseases including any kind of malignancies or
respiratory disease, and the presence and histologic type of
synchronous malignancy.
CT Scanning
Unenhanced CT was performed with two kinds of multi-
detector helical CT scanners (Light Speed Ultra, GE
Medical Systems, Milwaukee, WI; Sensation-16, Siemens
Medical Systems, Forchheim, Germany) in all the eight
patients. Specific parameters are given for the following
settings: for the Light Speed Ultra CT scanner that was
used for five patients, the peak tube voltage was 120 kVp,
the tube current was 400 mAs, the rotation time was 0.6
seconds, the reconstruction thickness was 1.25 mm and the
detector configuration was 8-detector rows with a pitch of
0.875; for the Sensation-16 CT scanner that was used for
the remaining three patients, the peak tube voltage was
140 kVp, the tube current was 250 mAs, the rotation time
was 0.5 seconds, the reconstruction thickness was 1.00 mm
and the detector configuration was 16-detector rows with a
pitch of 1.00. Each patient underwent chest CT examina-
tion for an average of 2.25 times (range: one to three
times) before surgery, and seven patients had follow-up
chest CT performed. The interval between the initial scan
and the last CT scan before surgery was 33 to 540 days,
with an average of 145.3 days. 
CT Findings and the Pathologic Features of AAH
Four radiologists (C.M.P., H.J.L., C.H.L., and J.M.G.)
analyzed all the CT images using the lung setting (a
window level of  700 HU and a width of 1,500 HU). Any
discrepancies were resolved by consensus. The CT findings
of each AAH lesion were recorded as follows: (a) multiplic-
ity, (b) location of the lesion, (c) shape (round, oval,
polygonal or irregular), (d) size and internal density of the
lesion, (e) interface between the normal lung and the lesion
(well-defined or poorly-defined), (f) internal features
within the lesion (pure ground-glass opacity [GGO], mixed
GGO, solid), and (g) any change of the lesion on the
follow-up CT scans.
The size and internal density (HU) of each lesion was
measured at the largest section of the lesion by one radiol-
ogist (C.M.P.), and a region of interest (ROI) was set on the
whole area of the lesion. Great effort was made to avoid
the vessels. GGO was defined as a hazy opacity that did
not obscure the underlying pulmonary vessels (9). We
evaluated the follow-up CT scans by consensus with
paying great attention to any change of the lesion, includ-
ing size, internal density, marginal characteristics and the
presence of solid component. This evaluation was
conducted by displaying two image sets side by side on a
liquid crystal display monitor for the seven patients having
follow-up CT images. 
The AAH lesions were microscopically evaluated by
conventional hematoxylin-eosin (H-E) staining. The cases
were diagnosed according to the 1999 WHO classification
(10). Pathologic sections of the each resected lesion were
compared to the corresponding CT images. These compar-
isons were performed via a consensus between a patholo-
gist (D.H.C.) and a radiologist (J.M.G.). 
RESULTS
The clinical features and CT findings for the eight
patients with AAH are summarized in Table 1. Three
patients had multiple AAH nodules and five patients had a
single AAH.
Clinical Features of AAH Patients
The eight patients consisted of three men and five
women, and their ages ranged from 43 to 71 years (mean
age: 57.6 years), and all patients were never-smokers. Six
individuals were asymptomatic and their AAH nodules
were incidentally detected by the CT screening for lung
cancer. Two patients had symptoms, which were blood-
tinged sputum and dyspnea, respectively. Two patients had
past history of other primary neoplasms; one had uterine
cervix cancer, and the other had benign solitary fibrous
tumor of the pleura. Four of them (50%) had synchronous
malignancies in the lung (Fig. 1); adenocarcinoma of the
lung (n = 3), and metastatic squamous cell carcinoma from
the uterus (n = 1). 
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aCT Findings and the Pathologic Features of AAH
By means of CT, we could identify and evaluate 11
pathologically proven AAH nodules in seven patients. In
one patient, thin section CT could not demonstrate a 2 mm
subpleural AAH. Three patients had multiple nodular
GGOs that were representative of multiple AAHs. Seven
AAH lesions (64%) were located in the upper lobe. In all
cases, the AAHs appeared as round or oval shapes, the
interface between the AAHs and the normal lung
parenchyma was well-defined and the margin was smooth
(Fig. 2). Vascular convergency or pleural retraction was
not detected. The lesion sizes were measured as 3.9 3
mm to 19 17 mm, and internal densities were measured
as  467 to  785 HU with a mean of  648.9 HU on their
initial diagnostic images, and all the AAHs showed pure
GGO without any solid component in it. There were no
changes in the AAH lesions for the seven patients with
follow-up CT.
In patient 7, there were disseminated nodular GGOs in
the bilateral lungs (Fig. 3). One of the nodular GGO lesions
in the right lower lobe was diagnosed as bronchioloalveo-
lar carcinoma (BAC) and the other lesions were diagnosed
as multiple AAHs in the right upper lobe and in the right
lower lobe wedge-resection specimen. Because the pure
GGO nodules seen on the CT scan and the AAHs in the
pathologic specimen were numerous, lesion by lesion
comparison was possible for only one AAH in the right
upper lobe. 
In patient 8, the screening CT that was done for detect-
ing lung cancer discovered a 6 mm well-defined solid
nodule in the left upper lobe; left upper lobe wedge
resection was done for this lesion. Pathologic examination
revealed a focal atelectatic lung for this lesion, and a 2 mm
AAH in the subpleural area was also incidentally detected. 
DISCUSSION
Since the introduction of mass screening for lung cancer
using spiral CT, small pulmonary nodules have been
detectable, and previously, these could not discovered by
plain radiography; further, small peripheral lung cancer has
been detected more easily and frequently (3, 11, 12).
However, as performing screening CT has shown an
increasing number of small indeterminate nodules, an
emerging concern is whether or not these lesions require
additional diagnostic steps such as follow-up, and also
whether they require pathology-confirming procedures
such as resection. AAH is now the focus of this issue.
In the clinicopathologic literature, the incidence of AAH
is 2.8% in the over-all age group (13) and it is 6.6% in the
elder group (14). Additionally, this tumor occurs much
more frequently in the cancer populations, and especially
lung cancer patients, and the incidence ranges from 10% to
23.2% (14 16). However, according to Kawakami et al.’s
prospective study (17), AAH is very rare in asymptomatic
individuals, and its incidence is about 0.05%. This discrep-
ancy in the incidence could be explained in that only
limited detection of AAH is based on radiologic methods,
including thin section CT, and most AAH lesions are very
small in size and they have low contrast on the radiologic
images. Actually, Kawakami et al. (17) identified the AAH
lesions that could be detected on HRCT. We could detect a
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Fig. 1. A 71-year-old woman with adenocarcinoma in the right upper lobe and atypical adenomatous hyperplasia in the left lower lobe.
A. The transverse thin section CT scan shows an 11.7 9 mm well-defined round nodule (arrowheads) with pure ground-glass opacity in
the left lower lobe and a 30 27 mm mixed ground-glass opacity lesion (arrow) in the right upper lobe. Note the solid portion of the right
upper lobe lesion.
B. Photomicrograph of the left lower lobe superior segmentectomy specimen (H & E staining,  40) shows atypical epithelial cell prolifer-
ation along the thickened alveolar septa, which is consistent with atypical adenomatous hyperplasia.
AB3.9 3 mm  sized AAH lesion on CT, yet one 2 mm
subpleural AAH was not identified. According to Ishikawa
(18) the detection rate of AAH lesions greater than 3 mm
in diameter is 57%, while that of the lesions smaller than 2
mm in diameter was 35%. 
In this study, all the AAH patients were never-smokers,
and this correlates well with a previous study (19). AAH
patients are usually asymptomatic (19), while two patients
in our study had symptoms; one had dyspnea and the
other had blood tinged sputum. The patient with dyspnea
had disseminated lesions throughout the bilateral lungs.
The other patient with blood tinged sputum had metastatic
squamous cell carcinoma from the uterine cervix in the
contralateral lung.
Atypical adenomatous hyperplasia has been thought to
be closely associated with malignancy and especially lung
cancer (14, 15). In our study, four of eight patients had
synchronous malignancies, particularly adenocarcinoma of
the lung, which is consistent with the other previous
reports (2, 14, 15). In recent years, multiple AAH lesions
have been thought to be closely associated with adenocar-
cinoma and particularly multiple adenocarcinomas (15,
20); this could suggest that AAH is a precursor lesion of
adenocarcinoma, and it supports the concept of the
multistep carcinogenesis process from AAH to adenocarci-
noma of the lung. In this study, two of three multiple AAH
patients (67%) had adenocarcinoma, and two of three
adenocarcinoma patients had multiple AAH lesions.
Seven AAH lesions that were demonstrated on CT
(64%) were located in the upper lobe, and on the
pathologic specimens, the predilection of upper lobe for
AAH was more distinct. In two previous studies (7, 17)
that both had less than ten cases each, a predilection for
the upper lobe was also demonstrated, although the reason
for this is not clear. Nakahara et al. (15) also reported that
AAH lesions were most frequently located in the upper
lobes in their study of 118 AAH cases. In our case with
disseminated nodular GGOs, these lesions were discovered
Park et al.
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AB
Fig. 2. A 53-year-old woman with a single atypical adenomatous
hyperplasia in the right lower lobe.
A. Transverse thin section CT scan shows an 11.2 10 mm well
defined round nodule with pure ground-glass opacity in the right
lower lobe. Note the pulmonary vessel penetrates the ground-glass
opacity lesion without any vascular compromise.
B. Photomicrograph (H & E staining,  10) shows that the
boundary between the atypical adenomatous hyperplasia and the
underlying lung parenchyma is distinct. Note the pulmonary vessel
penetrating the AAH lesion (black arrow).
C. High power photomicrograph (H & E staining,  100) shows
atypical epithelial cell proliferation along the thickened alveolar
septa, which is consistent with atypical adenomatous hyperplasia. 
Cthroughout the whole lungs with predominance for the
upper lung. Many of the nodular GGOs that remained
undiagnosed were probably mostly AAHs but some of
them could have been BACs, the same as the one nodule
in the right lower lobe.
We had four AAH lesions greater than 10 mm in size.
Some authors (20) insisted that the persistent nodular
GGO greater than 10 mm were carcinoma without
exception; however, other authors (17) have reported the
case of an AAH greater than 10 mm in size, as was seen in
our study. Although AAH is usually smaller than
adenocarcinoma or BAC, the lesion size can not be used as
the diagnosis criteria.
Atypical adenomatous hyperplasia has been described as
a focal nodular GGO lesion on CT (7, 17, 18). GGO of
AAH is thought to represent the unique replacement
growth pattern of the lesion. Our results in this study are
totally consistent with those of the previous studies that
AAH shows well-defined oval or round GGO without any
central solid component (11, 20) and the internal density
of AAHs in our study was similar with the result of a
previous study (17). However, nodular GGO is one of the
prevalent findings detected by CT. Meticulous evaluation
of the shape and border of the focal GGO and particularly,
the lesional change on the follow-up CT could be helpful to
differentiate AAH from other benign diseases that manifest
as focal GGOs. A recent study has suggested that these
nodular GGOs can be found with the aid of computer
systems (21).
In conclusion, AAH is often associated with malignancy.
It is observed as persistent, well-defined oval or round
nodular GGOs without solid components on CT, and it
does not change on the follow-up CT.
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AB
Fig. 3. A 59-year-old woman with disseminated nodular ground-
glass opacitys in the bilateral lungs. Wedge resections for the right
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